FDA Determines Regulatory Review Period for X-STOP INTERSPINOUS PROCESS DECOMPRESSION SYSTEM Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the X-STOP INTERSPINOUS PROCESS DECOMPRESSION SYSTEM medical device, following a patent extension application submitted to the US Department of Commerce.